Adaptive Immunity Contributes to the Progressive Pathology of Multiple Sclerosis: Implications for Clinical Development

Time: 3:45 pm
day: Day Two


• Progression Independent of Relapse Activity (PIRA) – what it is and why it matters.

• Meningeal aggregates in MS – stable, pathogenic, resistant to current therapies

• Imaging shows, for the first time, tissue injury associated with CNS compartmentalized progressive pathology of MS